Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors

Abstract excerpt

Drug-resistant superbugs pose a huge threat to human health. Infections by Enterobacteriaceae producing metallo-β-lactamases (MBLs), e.g., New Delhi metallo-β-lactamase 1 (NDM-1) are very difficult to treat. Development of effective MBL inhibitors to revive the efficacy of existing antibiotics is highly desirable. However, such inhibitors are not clinically available till now. Here we show that an...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antibiotic Resistance in Bacteria
• Share to Pneumocystis jirovecii pneumonia detection and treatment
• Share to Tuberculosis Research and Epidemiology